News

Centre for Innovation in Regulatory Science Awarded a $1.09m Grant to Help Accelerate Registration of Medicines in Low and Middle Income Countries

Metrics will inform, monitor and assess the effectiveness of regulatory optimisation programmes London, UK.  March 9, 2020: The Centre for Innovation in Regulatory Science (CIRS), a neutral and independent, international member-based organisation headquartered in the UK, has been awarded a phase two grant of $1.09m by the Bill & Melinda Gates Foundation to continue their collaborative […]

Clarivate Analytics closes acquisition of Decision Resources Group

— Creates a leading information insight solutions provider to the Life Sciences industry, helping them improve human lives — London, UK, & Philadelphia, US, March 2, 2020 – Clarivate Analytics plc (NYSE:CCC; CCC.WS) (“Clarivate”), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced it has completed its acquisition […]

Clarivate Reports Q4 and Full Year 2019 Results

— Updates 2020 Outlook for Acquisition of Decision Resources Group — London, UK and Philadelphia, US — February 27, 2020 – Clarivate Analytics Plc (NYSE: CCC, CCC.WS) (the “Company” or “Clarivate”), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today reported results for the fourth quarter and full […]

Clarivate Analytics to Present at the Morgan Stanley Technology, Media & Telecom Conference on March 2, 2020

London, UK, & Philadelphia, US, February 25, 2020 – Clarivate Analytics plc (NYSE:CCC; CCC.WS) (the “Company”), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced that Jerre Stead, Executive Chairman and CEO, will present at the Morgan Stanley Technology, Media & Telecom Conference on Monday, March 2, 2020 in San Francisco. The presentation is scheduled for 4:20 p.m. Pacific Time (7:20 p.m. Eastern Time).

City of Chandler and Clarivate Analytics Announce New Center of Excellence

CHANDLER, Ariz. February 21, 2020 – The City of Chandler today announced that Clarivate Analytics plc, a global leader in providing trusted insights and analytics to accelerate the pace of innovation, has signed a 30,000 square foot lease at Chandler Viridian, located in the Price Corridor Employment Center at 3133 W. Frye Road. Clarivate expects to employ approximately 150 people at this Class A office building.

Clarivate Analytics Plc Announces Redemption of Public Warrants

London, UK, & Philadelphia, US, February 20, 2020—Clarivate Analytics Plc (NYSE:CCC; CCC.WS) (the “Company”), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced that the Company will redeem all of its outstanding warrants (the “Public Warrants”) to purchase ordinary shares of the Company, no par value (the […]

New Clarivate Analytics Report Reveals Emergence of Market Disrupters is Fragmenting Global Patent Landscape, Diluting Leading Innovators’ Invention Market Share

London, UK, and Philadelphia, US, February 19, 2020 — The global innovation environment is rapidly fragmenting as large organizations[2] share of global inventions drops to 18% in the face of competition from market disruptors. This is according to the Derwent Top 100 Global Innovators 2020 report, released today by Clarivate Analytics Plc (NYSE:CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation.

Clarivate Analytics Plc Announces Closing of Offering of Ordinary Shares

London, UK, and Philadelphia, US, February 10, 2020—Clarivate Analytics Plc (NYSE:CCC; CCC.WS) (the “Company”), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced the closing of its previously announced underwritten offering of 27.6 million ordinary shares at $20.25 per share, which includes 3.6 million shares sold upon […]

Medicines that Treat High Prevalence Conditions Offer Hope to Many as the Annual Drugs to Watch List from Clarivate Identifies 11 New Blockbusters Forecasted to Launch in 2020

PHILADELPHIA & LONDON, February 10, 2020: Clarivate Analytics plc (NYSE: CCC; CCC.WS), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced the launch of its annual Cortellis “Drugs to Watch ” list, which identifies 11 new drugs that are scheduled to enter the market in 2020 and predicted to achieve annual sales of $1 billion or more (i.e., blockbuster status) by 2024.

Our policy towards the use of cookies
All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
close